leucodin has been researched along with dihydroergocristine monomesylate in 2 studies
| Studies (leucodin) | Trials (leucodin) | Recent Studies (post-2010) (leucodin) | Studies (dihydroergocristine monomesylate) | Trials (dihydroergocristine monomesylate) | Recent Studies (post-2010) (dihydroergocristine monomesylate) |
|---|---|---|---|---|---|
| 26 | 0 | 15 | 13 | 0 | 4 |
| Protein | Taxonomy | leucodin (IC50) | dihydroergocristine monomesylate (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.239 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.002 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 3 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 3.308 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0015 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0079 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0087 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0007 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 1.179 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0074 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.015 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.239 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0007 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 3 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.85 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0023 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0066 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
2 other study(ies) available for leucodin and dihydroergocristine monomesylate
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |